These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3672569)

  • 1. Altered protein binding of disopyramide in plasma from patients with cancer and with inflammatory disease.
    Echizen H; Saima S; Umeda N; Ishizaki T
    Ther Drug Monit; 1987 Sep; 9(3):272-8. PubMed ID: 3672569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein binding of disopyramide in liver cirrhosis and in nephrotic syndrome.
    Echizen H; Saima S; Umeda N; Ishizaki T
    Clin Pharmacol Ther; 1986 Sep; 40(3):274-80. PubMed ID: 3742934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers.
    Echizen H; Nakura M; Saotome T; Minoura S; Ishizaki T
    Br J Clin Pharmacol; 1990 Apr; 29(4):423-30. PubMed ID: 2183867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases.
    Echizen H; Saima S; Ishizaki T
    Br J Clin Pharmacol; 1987 Aug; 24(2):199-206. PubMed ID: 3620294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
    David BM; Ilett KF; Whitford EG; Stenhouse NS
    Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.
    David BM; Tjokrosetio R; Ilett KF
    Ther Drug Monit; 1983; 5(1):81-6. PubMed ID: 6845403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood.
    Bredesen JE; Kierulf P
    Br J Clin Pharmacol; 1986 Sep; 22(3):281-6. PubMed ID: 3768240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for estimating plasma unbound disopyramide concentrations in patients with varying plasma alpha 1-acid glycoprotein concentrations.
    Echizen H; Ishikawa S; Koike K; Ishizaki T
    Ther Drug Monit; 1995 Apr; 17(2):145-52. PubMed ID: 7624903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total and free disopyramide by fluorescence polarization immunoassay and relationship between free fraction and alpha-1 acid glycoprotein.
    Chen BH; Taylor EH; Pappas AA
    Clin Chim Acta; 1987 Feb; 163(1):75-80. PubMed ID: 3552331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the binding capacity of alpha-1-acid glycoprotein in patients with renal insufficiency.
    Kishino S; Nomura A; Di ZS; Sugawara M; Iseki K; Kakinoki S; Kitabatake A; Miyazaki K
    Ther Drug Monit; 1995 Oct; 17(5):449-53. PubMed ID: 8585106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function.
    Pedersen LE; Bonde J; Graudal NA; Backer NV; Hansen JE; Kampmann JP
    Br J Clin Pharmacol; 1987 Jan; 23(1):41-6. PubMed ID: 3814461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute changes in serum binding of disopyramide and flecainide after myocardial infarction.
    Caplin JL; Johnston A; Hamer J; Camm AJ
    Eur J Clin Pharmacol; 1985; 28(3):253-5. PubMed ID: 4007029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients.
    Haughey DB; Kraft CJ; Matzke GR; Keane WF; Halstenson CE
    Am J Nephrol; 1985; 5(1):35-9. PubMed ID: 3881959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of blood collection technique on serum and plasma protein binding of disopyramide.
    Haughey DB; Lima JJ
    Eur J Clin Pharmacol; 1982; 22(2):185-9. PubMed ID: 7094989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.
    Bredesen JE; Kierulf P
    Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1-acid glycoprotein concentration and the protein binding of disopyramide in healthy subjects.
    Kishino S; Nomura A; Di ZS; Sugawara M; Iseki K; Kakinoki S; Kitabatake A; Miyazaki K
    J Clin Pharmacol; 1995 May; 35(5):510-4. PubMed ID: 7657852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of age and smoking on the elimination of disopyramide.
    Bonde J; Pedersen LE; Bødtker S; Angelo HR; Svendsen TL; Kampmann JP
    Br J Clin Pharmacol; 1985 Nov; 20(5):453-8. PubMed ID: 4074615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.
    Lima JJ; Boudoulas H; Blanford M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):741-7. PubMed ID: 7299695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of disopyramide enantiomers for sites on plasma protein.
    Lima JJ
    Life Sci; 1987 Dec; 41(26):2807-13. PubMed ID: 3695808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.